Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MODIFIED LABELING FOR POLYDERM WBC(TM)

K-Number: K890940 · 1989-04-17

ApplicantLaivan Corp.
Decision Date1989-04-17
Product CodeNAD
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

MODIFIED LABELING FOR POLYDERM WBC(TM) is the device name listed in this FDA 510(k) record. The listed applicant is Laivan Corp.. It received FDA 510(k) clearance on 1989-04-17 under 510(k) number K890940. The device is classified under product code NAD. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MODIFIED LABELING FOR POLYDERM WBC(TM)?

MODIFIED LABELING FOR POLYDERM WBC(TM) is a medical device that received FDA 510(k) clearance on 1989-04-17. The listed applicant is Laivan Corp.. The 510(k) number is K890940.

When did MODIFIED LABELING FOR POLYDERM WBC(TM) receive FDA 510(k) clearance?

MODIFIED LABELING FOR POLYDERM WBC(TM) received FDA 510(k) clearance on 1989-04-17, under 510(k) number K890940.

Who is the listed applicant for MODIFIED LABELING FOR POLYDERM WBC(TM)?

The FDA 510(k) record lists Laivan Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MODIFIED LABELING FOR POLYDERM WBC(TM)?

The FDA product code for MODIFIED LABELING FOR POLYDERM WBC(TM) is NAD.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Laivan Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K923815TOTAL PROTECTIVE BREATHEABLE SURGICAL GOWNSK885205AQUADERMK880153POLYDERM A+B(TM)K880964POLYDERM PEC(TM), POROUS ELASTIC COVERK880206POLYDERM WBC (TM), WATERPROOF BREATHABLE COVER

Related Devices (Code: NAD)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K254246LT Antibacterial Foam with Silver DressingZhejiang Longterm Medical Technology Co., Ltd.K102403SAM CHEST SEAL WITH VAVLE; SAM CHEST SEALSam Medical ProductsK091133APLION TOPICAL CARE SYSTEMAplion Medical,LlcK072560ENVELA (HYDROHESIVE OCCLUSIVE DRESSING)Teikoku Pharma USA, Inc.K080524CENTURION SORBAVIEW OTCTri-State Hospital Supply Corp.K060046DERMASTREAMEnzysurge , Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑